Case Report: Intranasal esketamine combined with a form of generative artificial intelligence in the management of treatment-resistant depression
IntroductionIntranasal Esketamine is an effective rapid-acting antidepressant currently used to treat treatment-resistant depression. Artificial intelligence is another emerging tool in medicine, but little is known about the effectiveness of combining these innovations in psychiatry.MethodsThis cas...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Psychiatry |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1536232/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|